Literature DB >> 5312507

Four families with the dominant infantile form of optic nerve atrophy.

C C Kok-van Alphen.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5312507     DOI： 10.1111/j.1755-3768.1970.tb08211.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN： 0001-639X


× No keyword cloud information.
  7 in total

1.  A family with sex linked optic atrophy : Ophthalmological and neurological aspects.

Authors:  H J Völker-Dieben; G H Van Lith; L N Went; J W Klawer; A Staal; E C De Vries-De Mol
Journal:  Doc Ophthalmol       Date:  1974-11       Impact factor: 2.379

Review 2.  Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.

Authors:  M Votruba; A T Moore; S S Bhattacharya
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

3.  Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.

Authors:  M Votruba; D Thiselton; S S Bhattacharya
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome.

Authors:  J J Assink; N T Tijmes; J B ten Brink; R J Oostra; F C Riemslag; P T de Jong; A A Bergen
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

Review 5.  A review of primary hereditary optic neuropathies.

Authors:  M Votruba; S Aijaz; A T Moore
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Physiological evidence for impairment in autosomal dominant optic atrophy at the pre-ganglion level.

Authors:  Aldina Reis; Catarina Mateus; Teresa Viegas; Ralph Florijn; Arthur Bergen; Eduardo Silva; Miguel Castelo-Branco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-04       Impact factor: 3.117

7.  The Pattern of Retinal Ganglion Cell Loss in OPA1-Related Autosomal Dominant Optic Atrophy Inferred From Temporal, Spatial, and Chromatic Sensitivity Losses.

Authors:  Anna Majander; Catarina João; Andrew T Rider; G Bruce Henning; Marcela Votruba; Anthony T Moore; Patrick Yu-Wai-Man; Andrew Stockman
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.